title: Inhibition and activation studies on sheep liver sorbitol dehydrogenase.
abstract: Reversible inhibition and activation, as well as protection against affinity labelling with DL-2-bromo-3-(5-imidazolyl)propionic acid, of sheep liver sorbitol dehydrogenase have been studied. The results presented are discussed in terms of enzyme active-site properties and may have potential applications for drug design. Kinetics with mainly sorbitol competitive inhibitors reveals that aliphatic thiols are generally the most potent inhibitors of enzyme activity. Inhibition and inactivation by heterocyclics parallel that seen previously with sorbitol dehydrogenase from other sources as well as with alcohol dehydrogenase from yeast. However, there are significant differences in relation to the structurally similar horse liver alcohol dehydrogenase, as the catalytic zinc of sorbitol dehydrogenase is more easily removed by chelating molecules. Several aldose reductase inhibitors are shown to also inhibit sorbitol dehydrogenase, but at concentrations unlikely to be reached clinically. Enzyme activation has been observed with various compounds, in particular halo-alcohols and detergents. Several inhibitors provide competitive protection against enzyme inactivation by DL-2-bromo-3-(5-imidazolyl)propionic acid. This enables the dissociation constants for binary enzyme-inhibitor complexes to be determined. NADH protects noncompetitively against inactivation. The presence of some binary and ternary enzyme-NADH complexes is indicated from fluorescence emission spectra, as a shift in the fluorescence maximum and intensity is observed due to their formation.
authors.affiliation: Institute of Biochemistry, University of Oslo, Blindern, Norway.
authors.forename: R I
authors.initials: RI
authors.lastname: Lindstad
authors.forename: L F
authors.initials: LF
authors.lastname: Hermansen
authors.forename: J S
authors.initials: JS
authors.lastname: McKinley-McKee
mesh_terms: D000345:Affinity Labels / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007093:Imidazoles / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D007064:L-Iditol 2-Dehydrogenase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D008099:Liver / Q000201:enzymology*; D009243:NAD / Q000378:metabolism / Q000494:pharmacology; D012756:Sheep; D013050:Spectrometry, Fluorescence; D013237:Stereoisomerism
chemical_list: D000345:Affinity Labels; D004791:Enzyme Inhibitors; D007093:Imidazoles; D009243:NAD; C000314:alpha-bromo-beta-(5-imidazolyl)propionic acid; D007064:L-Iditol 2-Dehydrogenase